Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hodgkin Disease × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 7 Brain Neoplasms 6 Sarcoma 4 Carcinoma, Hepatocellular 4 Solid Tumor, Adult 3 Carcinoma, Non-Small-Cell Lung 3 Pituitary Neoplasms 2 Meningioma 2 Liver Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Thoracic Neoplasms 1 Solid Tumor 1 Rhabdomyosarcoma 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Pediatric Cancer Patients 1 Parotid Neoplasms 1 Neuroblastoma 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Malignant Brain Glioma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 10 Peripheral Blood Stem Cell Transplantation 10 Whole-Body Irradiation 8 Cyclosporine 8 Melphalan 7 Antilymphocyte Serum 7 Mycophenolic Acid 6 fludarabine 5 Radiotherapy 5 Filgrastim 5 Busulfan 5 Psychiatric Rehabilitation 4 Etoposide 4 Cytarabine 4 Blood Specimen Collection 4 thymoglobulin 3 Therapeutics 3 Rituximab 3 Methylprednisolone 3 Methotrexate 3 Flow Cytometry 3 Carmustine 3 Stem Cell Transplantation 2 Polymerase Chain Reaction 2 Music Therapy 2 Methods 2 Mesna 2 Magnetic Resonance Spectroscopy 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06883604 2025-03-19

PRO-Hodgkin

Uppsala University Hospital

Phase NA Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡